Shares of NeuroBo Pharmaceutical (NASDAQ: NRBO) shot up in morning trading on Tuesday following news of a 1-for-30 reverse stock split. Beginning today, the stock began to trade on the NASDAQ on a split-adjusted basis. Following this stock split, the number of authorized shares will remain at 100 million but the number of outstanding shares will stand at 0.9 million, from 26.7 million earlier.
https://www.tipranks.com/news/neurobo-pharma-nasdaq-nrbo-shoots-up-following-reverse-stock-split?utm_source=advfn.com&utm_medium=referral
NeuroBo Pharmaceuticals (NASDAQ:NRBO)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more NeuroBo Pharmaceuticals Charts.
NeuroBo Pharmaceuticals (NASDAQ:NRBO)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more NeuroBo Pharmaceuticals Charts.